472 related articles for article (PubMed ID: 32985222)
1. A novel, injury-free rodent model of vulnerability for assessment of acute and preventive therapies reveals temporal contributions of CGRP-receptor activation in migraine-like pain.
Kopruszinski CM; Navratilova E; Swiokla J; Dodick DW; Chessell IP; Porreca F
Cephalalgia; 2021 Mar; 41(3):305-317. PubMed ID: 32985222
[TBL] [Abstract][Full Text] [Related]
2. Characterization and preclinical evaluation of a protease activated receptor 2 (PAR2) monoclonal antibody as a preventive therapy for migraine.
Kopruszinski CM; Thornton P; Arnold J; Newton P; Lowne D; Navratilova E; Swiokla J; Dodick DW; Dobson C; Gurrell I; Chessell IP; Porreca F
Cephalalgia; 2020 Dec; 40(14):1535-1550. PubMed ID: 33131305
[TBL] [Abstract][Full Text] [Related]
3. Dysregulation of serum prolactin links the hypothalamus with female nociceptors to promote migraine.
Watanabe M; Kopruszinski CM; Moutal A; Ikegami D; Khanna R; Chen Y; Ross S; Mackenzie K; Stratton J; Dodick DW; Navratilova E; Porreca F
Brain; 2022 Aug; 145(8):2894-2909. PubMed ID: 35325034
[TBL] [Abstract][Full Text] [Related]
4. Kappa opioid receptor antagonists: A possible new class of therapeutics for migraine prevention.
Xie JY; De Felice M; Kopruszinski CM; Eyde N; LaVigne J; Remeniuk B; Hernandez P; Yue X; Goshima N; Ossipov M; King T; Streicher JM; Navratilova E; Dodick D; Rosen H; Roberts E; Porreca F
Cephalalgia; 2017 Jul; 37(8):780-794. PubMed ID: 28376659
[TBL] [Abstract][Full Text] [Related]
5. Ubrogepant does not induce latent sensitization in a preclinical model of medication overuse headache.
Navratilova E; Behravesh S; Oyarzo J; Dodick DW; Banerjee P; Porreca F
Cephalalgia; 2020 Aug; 40(9):892-902. PubMed ID: 32615788
[TBL] [Abstract][Full Text] [Related]
6. CGRP-dependent and independent mechanisms of acute and persistent post-traumatic headache following mild traumatic brain injury in mice.
Navratilova E; Rau J; Oyarzo J; Tien J; Mackenzie K; Stratton J; Remeniuk B; Schwedt T; Anderson T; Dodick D; Porreca F
Cephalalgia; 2019 Dec; 39(14):1762-1775. PubMed ID: 31550910
[TBL] [Abstract][Full Text] [Related]
7. Kappa opioid receptor agonists produce sexually dimorphic and prolactin-dependent hyperalgesic priming.
Kopruszinski CM; Watanabe M; Martinez AL; de Souza LHM; Dodick DW; Moutal A; Neugebauer V; Porreca F; Navratilova E
Pain; 2023 Jun; 164(6):e263-e273. PubMed ID: 36625833
[TBL] [Abstract][Full Text] [Related]
8. Targeting CGRP via receptor antagonism and antibody neutralisation in two distinct rodent models of migraine-like pain.
Christensen SL; Petersen S; Kristensen DM; Olesen J; Munro G
Cephalalgia; 2019 Dec; 39(14):1827-1837. PubMed ID: 31288556
[TBL] [Abstract][Full Text] [Related]
9. Dural Calcitonin Gene-Related Peptide Produces Female-Specific Responses in Rodent Migraine Models.
Avona A; Burgos-Vega C; Burton MD; Akopian AN; Price TJ; Dussor G
J Neurosci; 2019 May; 39(22):4323-4331. PubMed ID: 30962278
[TBL] [Abstract][Full Text] [Related]
10. Acetaldehyde via CGRP receptor and TRPA1 in Schwann cells mediates ethanol-evoked periorbital mechanical allodynia in mice: relevance for migraine.
Landini L; Souza Monteiro de Araujo D; Chieca M; De Siena G; Bellantoni E; Geppetti P; Nassini R; De Logu F
J Biomed Sci; 2023 Apr; 30(1):28. PubMed ID: 37101198
[TBL] [Abstract][Full Text] [Related]
11. A Female-Specific Role for Calcitonin Gene-Related Peptide (CGRP) in Rodent Pain Models.
Paige C; Plasencia-Fernandez I; Kume M; Papalampropoulou-Tsiridou M; Lorenzo LE; David ET; He L; Mejia GL; Driskill C; Ferrini F; Feldhaus AL; Garcia-Martinez LF; Akopian AN; De Koninck Y; Dussor G; Price TJ
J Neurosci; 2022 Mar; 42(10):1930-1944. PubMed ID: 35058371
[TBL] [Abstract][Full Text] [Related]
12. Recurrent administration of the nitric oxide donor, isosorbide dinitrate, induces a persistent cephalic cutaneous hypersensitivity: A model for migraine progression.
Dallel R; Descheemaeker A; Luccarini P
Cephalalgia; 2018 Apr; 38(4):776-785. PubMed ID: 28565942
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of LY573144 (lasmiditan) in a preclinical model of medication overuse headache.
Rau JC; Navratilova E; Oyarzo J; Johnson KW; Aurora SK; Schwedt TJ; Dodick DW; Porreca F
Cephalalgia; 2020 Aug; 40(9):903-912. PubMed ID: 32580575
[TBL] [Abstract][Full Text] [Related]
14. Contribution of intraganglionic CGRP to migraine-like responses in male and female rats.
Araya EI; Turnes JM; Barroso AR; Chichorro JG
Cephalalgia; 2020 Jun; 40(7):689-700. PubMed ID: 31856582
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Nociception in a Preclinical Episodic Migraine Model by Dietary Supplementation of Grape Seed Extract Involves Activation of Endocannabinoid Receptors.
Woodman SE; Antonopoulos SR; Durham PL
Front Pain Res (Lausanne); 2022; 3():809352. PubMed ID: 35295808
[TBL] [Abstract][Full Text] [Related]
16. A c-Fos activation map in nitroglycerin/levcromakalim-induced models of migraine.
Wu S; Ren X; Zhu C; Wang W; Zhang K; Li Z; Liu X; Wang Y
J Headache Pain; 2022 Sep; 23(1):128. PubMed ID: 36180824
[TBL] [Abstract][Full Text] [Related]
17. The 'headache tree' via umbellulone and TRPA1 activates the trigeminovascular system.
Nassini R; Materazzi S; Vriens J; Prenen J; Benemei S; De Siena G; la Marca G; Andrè E; Preti D; Avonto C; Sadofsky L; Di Marzo V; De Petrocellis L; Dussor G; Porreca F; Taglialatela-Scafati O; Appendino G; Nilius B; Geppetti P
Brain; 2012 Feb; 135(Pt 2):376-90. PubMed ID: 22036959
[TBL] [Abstract][Full Text] [Related]
18. CGRP monoclonal antibody prevents the loss of diffuse noxious inhibitory controls (DNIC) in a mouse model of post-traumatic headache.
Kopruszinski CM; Turnes JM; Swiokla J; Weinstein TJ; Schwedt TJ; Dodick DW; Anderson T; Navratilova E; Porreca F
Cephalalgia; 2021 May; 41(6):749-759. PubMed ID: 33615840
[TBL] [Abstract][Full Text] [Related]
19. Antagonism of CGRP Receptor: Central and Peripheral Mechanisms and Mediators in an Animal Model of Chronic Migraine.
Greco R; Demartini C; Francavilla M; Zanaboni AM; Tassorelli C
Cells; 2022 Sep; 11(19):. PubMed ID: 36231054
[TBL] [Abstract][Full Text] [Related]
20. Calcitonin gene-related peptide receptor antagonism reduces motion sickness indicators in mouse migraine models.
Rahman SM; Luebke AE
Cephalalgia; 2024 Jan; 44(1):3331024231223971. PubMed ID: 38215227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
